192 related articles for article (PubMed ID: 28550707)
1. MicroRNAs Correlate with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder in a Chinese Population.
Chen J; Zhu J; Wang Z; Yao X; Wu X; Liu F; Zheng W; Li Z; Lin A
Med Sci Monit; 2017 May; 23():2565-2583. PubMed ID: 28550707
[TBL] [Abstract][Full Text] [Related]
2. Next-generation sequencing identifies altered whole blood microRNAs in neuromyelitis optica spectrum disorder which may permit discrimination from multiple sclerosis.
Keller A; Leidinger P; Meese E; Haas J; Backes C; Rasche L; Behrens JR; Pfuhl C; Wakonig K; Gieß RM; Jarius S; Meder B; Bellmann-Strobl J; Paul F; Pache FC; Ruprecht K
J Neuroinflammation; 2015 Oct; 12():196. PubMed ID: 26521232
[TBL] [Abstract][Full Text] [Related]
3. Extracellular miR-145, miR-223 and miR-326 expression signature allow for differential diagnosis of immune-mediated neuroinflammatory diseases.
Sharaf-Eldin WE; Kishk NA; Gad YZ; Hassan H; Ali MAM; Zaki MS; Mohamed MR; Essawi ML
J Neurol Sci; 2017 Dec; 383():188-198. PubMed ID: 29246612
[TBL] [Abstract][Full Text] [Related]
4. Potential Value of miR-23a for Discriminating Neuromyelitis Optica Spectrum Disorder from Multiple Sclerosis.
Sharaf-Eldin W; Kishk N; Sakr B; El-Hariri H; Refeat M; ElBagoury N; Essawi M
Arch Iran Med; 2020 Oct; 23(10):678-687. PubMed ID: 33107309
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of miR-125a-5p and miR-218-5p in Peripheral Blood Mononuclear Cells of Patients with Relapsing-Remitting Multiple Sclerosis.
Mosarrezaii Aghdam A; Rezaei S; Zarza Nalivan F; Babaie F; Amiri Nikpour MR; Torkamandi S
Immunol Invest; 2022 Jul; 51(5):1149-1161. PubMed ID: 33866949
[TBL] [Abstract][Full Text] [Related]
6. Different Exosomal microRNA Profile in Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorders.
Chen C; Wu Y; Li M; Cui C; Zhao Y; Sun X; Wang Y; Liu C; Wu H; Zhong X; Kermode AG; Peng L; Qiu W
Front Immunol; 2020; 11():1064. PubMed ID: 32547558
[TBL] [Abstract][Full Text] [Related]
7. Analysis of potential microRNA biomarkers for multiple sclerosis.
Al-Temaimi R; Alshammari N; Alroughani R
Exp Mol Pathol; 2024 Jun; 137():104903. PubMed ID: 38772208
[TBL] [Abstract][Full Text] [Related]
8. Neuromyelitis optica spectrum disorder and multiple sclerosis: Differentiation by a multimodal approach.
Ota M; Sato N; Okamoto T; Noda T; Araki M; Yamamura T; Kunugi H
Mult Scler Relat Disord; 2015 Nov; 4(6):515-20. PubMed ID: 26590657
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of remitting neuromyelitis optica spectrum disorders from multiple sclerosis by integrating parameters from serum proteins and lymphocyte subsets.
Ip PP; Chung CY; Chang CC; Lee YF; Wang HM; Lian IB; Fann CS; Yang CC; Liao F
J Neuroimmunol; 2018 May; 318():45-52. PubMed ID: 29455925
[TBL] [Abstract][Full Text] [Related]
10. The GTF2I rs117026326 polymorphism is associated with neuromyelitis optica spectrum disorder but not with multiple sclerosis in a Northern Han Chinese population.
Liang H; Gao W; Liu X; Liu J; Mao X; Yang M; Long X; Zhou Y; Zhang Q; Zhu J; Wang S; Jin T
J Neuroimmunol; 2019 Dec; 337():577045. PubMed ID: 31520790
[TBL] [Abstract][Full Text] [Related]
11. Multiplex Analysis of Cerebrospinal Fluid and Serum Exosomes MicroRNAs of Untreated Relapsing Remitting Multiple Sclerosis (RRMS) and Proposing Noninvasive Diagnostic Biomarkers.
Mohammadinasr M; Montazersaheb S; Molavi O; Kahroba H; Talebi M; Ayromlou H; Hejazi MS
Neuromolecular Med; 2023 Sep; 25(3):402-414. PubMed ID: 37020076
[TBL] [Abstract][Full Text] [Related]
12. miR-132-3p, miR-106b-5p, and miR-19b-3p Are Associated with Brain-Derived Neurotrophic Factor Production and Clinical Activity in Multiple Sclerosis: A Pilot Study.
Sağır F; Ersoy Tunalı N; Tombul T; Koral G; Çırak S; Yılmaz V; Türkoğlu R; Tüzün E
Genet Test Mol Biomarkers; 2021 Nov; 25(11):720-726. PubMed ID: 34788141
[No Abstract] [Full Text] [Related]
13. Serum neurofilament light chain and glial fibrillary acidic protein in AQP4-IgG-seropositive neuromyelitis optica spectrum disorders and multiple sclerosis: A cohort study.
Liu C; Lu Y; Wang J; Chang Y; Wang Y; Chen C; Liu Z; Kermode AG; Zhang Y; Qiu W
J Neurochem; 2021 Dec; 159(5):913-922. PubMed ID: 34278578
[TBL] [Abstract][Full Text] [Related]
14. Erythrocyte microRNA sequencing reveals differential expression in relapsing-remitting multiple sclerosis.
Groen K; Maltby VE; Lea RA; Sanders KA; Fink JL; Scott RJ; Tajouri L; Lechner-Scott J
BMC Med Genomics; 2018 May; 11(1):48. PubMed ID: 29783973
[TBL] [Abstract][Full Text] [Related]
15. Plasma complement biomarkers distinguish multiple sclerosis and neuromyelitis optica spectrum disorder.
Hakobyan S; Luppe S; Evans DR; Harding K; Loveless S; Robertson NP; Morgan BP
Mult Scler; 2017 Jun; 23(7):946-955. PubMed ID: 27613120
[TBL] [Abstract][Full Text] [Related]
16. Optical Coherence Tomography Reveals Distinct Patterns of Retinal Damage in Neuromyelitis Optica and Multiple Sclerosis.
Schneider E; Zimmermann H; Oberwahrenbrock T; Kaufhold F; Kadas EM; Petzold A; Bilger F; Borisow N; Jarius S; Wildemann B; Ruprecht K; Brandt AU; Paul F
PLoS One; 2013; 8(6):e66151. PubMed ID: 23805202
[TBL] [Abstract][Full Text] [Related]
17. Brain age gap in neuromyelitis optica spectrum disorders and multiple sclerosis.
Wei R; Xu X; Duan Y; Zhang N; Sun J; Li H; Li Y; Li Y; Zeng C; Han X; Zhou F; Huang M; Li R; Zhuo Z; Barkhof F; H Cole J; Liu Y
J Neurol Neurosurg Psychiatry; 2023 Jan; 94(1):31-37. PubMed ID: 36216455
[TBL] [Abstract][Full Text] [Related]
18. Comparison of probabilistic tractography and tract-based spatial statistics for assessing optic radiation damage in patients with autoimmune inflammatory disorders of the central nervous system.
Kuchling J; Backner Y; Oertel FC; Raz N; Bellmann-Strobl J; Ruprecht K; Paul F; Levin N; Brandt AU; Scheel M
Neuroimage Clin; 2018; 19():538-550. PubMed ID: 29984162
[TBL] [Abstract][Full Text] [Related]
19. Exosomal microRNA signatures in multiple sclerosis reflect disease status.
Ebrahimkhani S; Vafaee F; Young PE; Hur SSJ; Hawke S; Devenney E; Beadnall H; Barnett MH; Suter CM; Buckland ME
Sci Rep; 2017 Oct; 7(1):14293. PubMed ID: 29084979
[TBL] [Abstract][Full Text] [Related]
20. MiRNA 106a-5p in cerebrospinal fluid as signature of early relapsing remitting multiple sclerosis: a cross sectional study.
Zanghì A; Manuti V; Serviddio G; D'Amico E; Avolio C
Front Immunol; 2023; 14():1226130. PubMed ID: 37711630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
